Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

DSC Advisors, L.L.C. — ZEVRA THERAPEUTICS, INC. insider: 1 transactions · InsiderLens

Home / Insiders / DSC Advisors, L.L.C.

DSC Advisors, L.L.C.

10% owner at Neos Therapeutics, Inc. · on record since Jul 28, 2015
10% owner at ZEVRA THERAPEUTICS, INC. · on record since Sep 15, 2017

Insider trading activity of DSC Advisors, L.L.C.

Transactions on record: 1; since Aug 1, 2018

Open-market buys: 1; $1.2M

Open-market sells: 0

Companies traded: 1; last filing Aug 1, 2018

Figures computed from official regulatory filings — methodology.

Companies where DSC Advisors, L.L.C. has traded

ZEVRA THERAPEUTICS, INC.1 tx · $1.2M · Aug 1, 2018

Track record of DSC Advisors, L.L.C.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of DSC Advisors, L.L.C.

Co-insiders of DSC Advisors, L.L.C.

BLUHM ANDREW GNeos Therapeutics, Inc. +1
Delaware Street Capital Master Fund, L.P.Neos Therapeutics, Inc. +1
DSC Advisors, L.P.Neos Therapeutics, Inc. +1
DSC Managers, L.L.C.Neos Therapeutics, Inc. +1
Anderson ThomasZEVRA THERAPEUTICS, INC.
Bode John BZEVRA THERAPEUTICS, INC.
Braun Samuel JZEVRA THERAPEUTICS, INC.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

BURRILL LIFE SCIENES CAPITAL FUND III L PNeos Therapeutics, Inc.

Calder Douglas WZEVRA THERAPEUTICS, INC.

Castelein CaleyNeos Therapeutics, Inc.

Clifton R. LaDuaneZEVRA THERAPEUTICS, INC.

CMEA Ventures VII LPNeos Therapeutics, Inc.

CMEA VENTURES VII (PARALLEL) LPNeos Therapeutics, Inc.

Cohen Daniel LZEVRA THERAPEUTICS, INC.

Collier David JNeos Therapeutics, Inc.

Dalal AnupamNeos Therapeutics, Inc.

DELAWARE STREET CAPITAL L PNeos Therapeutics, Inc.

DIXON WENDY LZEVRA THERAPEUTICS, INC.

Edick Paul RNeos Therapeutics, Inc.

Eisenstadt Richard INeos Therapeutics, Inc.

Engelking DorothyNeos Therapeutics, Inc.

Essex Capital CorpNeos Therapeutics, Inc.

Fong BryantNeos Therapeutics, Inc.

Garg Vipin KNeos Therapeutics, Inc.

Guenther SvenZEVRA THERAPEUTICS, INC.

Hecht BethNeos Therapeutics, Inc.

HELLER ALAN LNeos Therapeutics, Inc.

Iannelli RalphNeos Therapeutics, Inc.

Johnson Gordon KZEVRA THERAPEUTICS, INC.

Kearny Venture Assoicates II LLCNeos Therapeutics, Inc.

Limongelli John MNeos Therapeutics, Inc.

Martens JuergenNeos Therapeutics, Inc.

McDonnell Thomas PNeos Therapeutics, Inc.

McFarlane Neil F.ZEVRA THERAPEUTICS, INC.

McLaughlin Gerald W.Neos Therapeutics, Inc.

Mickle Christal M MZEVRA THERAPEUTICS, INC.

Mickle Travis CZEVRA THERAPEUTICS, INC.

Pascoe Richard WZEVRA THERAPEUTICS, INC.

Plooster Matthew RZEVRA THERAPEUTICS, INC.

Posner ChristopherZEVRA THERAPEUTICS, INC.

Presidio Partners 2007 GP, LLCNeos Therapeutics, Inc.

Presidio Partners 2007 GP, L.P.Neos Therapeutics, Inc.

Quartel Adrian WZEVRA THERAPEUTICS, INC.

Renz Justin AZEVRA THERAPEUTICS, INC.

Robinson James A. Jr.Neos Therapeutics, Inc.

ROBITAILLE GREGORY JNeos Therapeutics, Inc.

Saluri JosephZEVRA THERAPEUTICS, INC.

Sangiovanni Timothy J.ZEVRA THERAPEUTICS, INC.

Schafer JoshuaZEVRA THERAPEUTICS, INC.

Schmid John P.Neos Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
ZEVRA THERAPEUTICS, INC.	Aug 1, 2018	Buy	304,283	4.00 USD	$1.2M	SEC